Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sander D Borgsteede

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Pharmacoepidemiology and Drug Safety|March 28, 2017
The burden and management of cytochrome P450 2D6 (CYP2D6)-mediated drug-drug interaction (DDI): co-medication of metoprolol and paroxetine or fluoxetine in the elderlyMuh Akbar Bahar, Eelko Hak, Jens H J Bos, et al.
Journal of Pain and Symptom Management|December 13, 2019
Recommendations for Safe Medication Use in Liver Impairment: Importance of Transparency and Reflections on Analgesics, Hypnotics, and Anti-emeticsSander D Borgsteede, Rianne A Weersink, Eric Geijteman, et al.
International Journal of Clinical Pharmacy|July 17, 2021
Management of drug-disease interactions: a best practice from the NetherlandsMaaike M E Diesveld, Suzanne de Klerk, Pieter Cornu, et al.
Plos One|May 30, 2018
Preventing dispensing errors by alerting for drug confusions in the pharmacy information system-A survey of usersZizi Campmans, Arianne van Rhijn, René M Dull, et al.
Pharmacy World & Science : PWS|January 16, 2010
Informational needs of general practitioners regarding discharge medication: content, timing and pharmacotherapeutic adviceFatma Karapinar, Patricia M L A van den Bemt, Jan Zoer, et al.
Patient Education and Counseling|June 18, 2010
Information needs about medication according to patients discharged from a general hospitalSander D Borgsteede, Fatma Karapinar-Çarkit, Emmy Hoffmann, et al.
Drug Safety|October 26, 2018
Prevalence of Drug Prescriptions and Potential Safety in Patients with Cirrhosis: A Retrospective Real-World StudyRianne A Weersink, Katja Taxis, Joost P H Drenth, et al.
Expert Opinion on Drug Metabolism & Toxicology|December 8, 2019
Safe use of medication in patients with cirrhosis: pharmacokinetic and pharmacodynamic considerationsRianne A Weersink, David M Burger, Kelly L Hayward, et al.
International Journal of Clinical Pharmacy|October 23, 2025
Barriers, facilitators, and implementation strategies for pharmacogenomics in community pharmacies: a cross-sectional survey among local champions in pharmacies and key opinion leaders in pharmacogenomicsPantea Kiani, Pierre M Bet, Naomi T Jessurun, et al.
Patient Education and Counseling|December 13, 2006
Communication about euthanasia in general practice: opinions and experiences of patients and their general practitionersSander D Borgsteede, Luc Deliens, Corrie Graafland-Riedstra, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Pharmacoepidemiology and Drug Safety|March 28, 2017
The burden and management of cytochrome P450 2D6 (CYP2D6)-mediated drug-drug interaction (DDI): co-medication of metoprolol and paroxetine or fluoxetine in the elderlyMuh Akbar Bahar, Eelko Hak, Jens H J Bos, et al.
Journal of Pain and Symptom Management|December 13, 2019
Recommendations for Safe Medication Use in Liver Impairment: Importance of Transparency and Reflections on Analgesics, Hypnotics, and Anti-emeticsSander D Borgsteede, Rianne A Weersink, Eric Geijteman, et al.
International Journal of Clinical Pharmacy|July 17, 2021
Management of drug-disease interactions: a best practice from the NetherlandsMaaike M E Diesveld, Suzanne de Klerk, Pieter Cornu, et al.
Plos One|May 30, 2018
Preventing dispensing errors by alerting for drug confusions in the pharmacy information system-A survey of usersZizi Campmans, Arianne van Rhijn, René M Dull, et al.
Pharmacy World & Science : PWS|January 16, 2010
Informational needs of general practitioners regarding discharge medication: content, timing and pharmacotherapeutic adviceFatma Karapinar, Patricia M L A van den Bemt, Jan Zoer, et al.
Patient Education and Counseling|June 18, 2010
Information needs about medication according to patients discharged from a general hospitalSander D Borgsteede, Fatma Karapinar-Çarkit, Emmy Hoffmann, et al.
Drug Safety|October 26, 2018
Prevalence of Drug Prescriptions and Potential Safety in Patients with Cirrhosis: A Retrospective Real-World StudyRianne A Weersink, Katja Taxis, Joost P H Drenth, et al.
Expert Opinion on Drug Metabolism & Toxicology|December 8, 2019
Safe use of medication in patients with cirrhosis: pharmacokinetic and pharmacodynamic considerationsRianne A Weersink, David M Burger, Kelly L Hayward, et al.
International Journal of Clinical Pharmacy|October 23, 2025
Barriers, facilitators, and implementation strategies for pharmacogenomics in community pharmacies: a cross-sectional survey among local champions in pharmacies and key opinion leaders in pharmacogenomicsPantea Kiani, Pierre M Bet, Naomi T Jessurun, et al.
Patient Education and Counseling|December 13, 2006
Communication about euthanasia in general practice: opinions and experiences of patients and their general practitionersSander D Borgsteede, Luc Deliens, Corrie Graafland-Riedstra, et al.
Pageof 6